You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 15, 2025

Drug Price Trends for BACLOFEN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for BACLOFEN

Average Pharmacy Cost for BACLOFEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BACLOFEN 20 MG TABLET 72888-0011-05 0.04889 EACH 2025-01-22
BACLOFEN 20 MG TABLET 72888-0011-01 0.04889 EACH 2025-01-22
BACLOFEN 20 MG TABLET 72888-0011-00 0.04889 EACH 2025-01-22
BACLOFEN 10 MG TABLET 72888-0010-05 0.03351 EACH 2025-01-22
BACLOFEN 10 MG TABLET 72888-0010-01 0.03351 EACH 2025-01-22
BACLOFEN 10 MG TABLET 72888-0010-00 0.03351 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for BACLOFEN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
BACLOFEN 20MG TAB AvKare, LLC 31722-0999-01 100 7.64 0.07640 EACH 2023-06-15 - 2028-06-14 FSS
BACLOFEN 20MG TAB AvKare, LLC 31722-0999-10 1000 76.39 0.07639 EACH 2023-06-15 - 2028-06-14 FSS
BACLOFEN 5MG TAB AvKare, LLC 00527-1333-01 100 64.91 0.64910 EACH 2023-06-15 - 2028-06-14 FSS
BACLOFEN 10MG TAB AvKare, LLC 31722-0998-01 100 5.72 0.05720 EACH 2023-06-15 - 2028-06-14 FSS
BACLOFEN 10MG TAB AvKare, LLC 31722-0998-10 1000 57.29 0.05729 EACH 2023-06-15 - 2028-06-14 FSS
GABLOFEN 0.1MG/ML PF INJ INTRATHECAL Piramal Critical Care, Inc. 66794-0156-02 20ML 260.05 13.00250 ML 2022-07-15 - 2027-07-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Baclofen Market Analysis and Price Projections

Market Overview

Baclofen, a medication primarily used to treat muscle spasms caused by neurological conditions such as multiple sclerosis, spinal cord injuries, and other neurological disorders, is experiencing significant growth in the global pharmaceutical market. Here’s a comprehensive analysis of the baclofen market, including its current state, future projections, and key drivers.

Market Size and Growth Projections

As of 2024, the global baclofen market was valued at approximately USD 16,524.27 million. It is projected to grow at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2034, reaching a market size of USD 30,976.43 million by 2034[1].

Regional Market Dynamics

North America

North America dominates the global baclofen market, accounting for around 38% of the market share in 2023. This dominance is attributed to the high prevalence of neurological conditions such as multiple sclerosis and spinal cord injuries in the region, particularly in the United States. The well-developed healthcare infrastructure, high healthcare spending, and widespread awareness of treatment options also contribute to this market leadership[1].

Europe

Europe is another significant market for baclofen, with notable demand in countries like Germany, France, and the UK. The region's high incidence of conditions leading to muscle spasticity and a strong focus on healthcare services drive the demand for baclofen in this area[1].

Other Regions

The Asia Pacific, Latin America, and Middle East & Africa regions are also expected to contribute to the growth of the baclofen market, driven by increasing awareness and improving healthcare infrastructure.

Key Drivers of Market Growth

Increasing Prevalence of Neurological Disorders

The rising incidence of neurological conditions such as multiple sclerosis, cerebral palsy, stroke, and spinal cord injuries is a major driver of the baclofen market. These conditions often result in muscle spasticity, for which baclofen is an effective treatment[2].

Advancements in Pharmaceutical Formulations

Improvements in pharmaceutical formulations have enhanced the efficacy and safety of baclofen, making it a preferred treatment option for muscle spasticity. This has contributed to the steady growth of the market[3].

Reimbursement Strategies

The implementation of supportive reimbursement strategies by healthcare systems and insurance entities has increased patient accessibility and affordability to baclofen treatments, including Intrathecal Baclofen (ITB) therapy. This has been a significant factor in the market's expansion[2].

Education and Awareness

The escalating dissemination of education and awareness about ITB therapy among patients, their families, and healthcare practitioners has also driven the demand for baclofen. As more people understand the benefits of ITB therapy, the market is expected to grow further[2].

Market Segments

Type of Baclofen

The market is segmented into different types of baclofen, including oral tablets, oral liquids, and intrathecal solutions. Each type has its own set of applications and user preferences, contributing to the overall market growth.

Oral Tablets and Liquids

Oral forms of baclofen are widely used due to their ease of administration and availability. The cost for oral baclofen tablets can range from $0.38 to $0.59 per unit, depending on the quantity and pharmacy[5].

Intrathecal Solutions

Intrathecal baclofen therapy involves direct administration into the spinal cord and is particularly effective for severe spasticity. The cost for intrathecal baclofen solutions can range from $250.22 to $798.10 for 20 milliliters, depending on the concentration and pharmacy[5].

Application

Baclofen is used in various applications, including the treatment of multiple sclerosis, spinal cord injuries, cerebral palsy, and other neurological disorders. Its efficacy in treating muscle spasticity makes it a versatile medication.

Distribution Channels

The market is also segmented by distribution channels, including hospitals & clinics, online pharmacies, and retail pharmacies. Each channel plays a crucial role in making baclofen accessible to patients.

Competitive Landscape

The baclofen market is competitive, with several major players such as Amneal Pharmaceuticals, Novartis AG, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, and others. These companies are involved in continuous research and development to improve formulations and delivery methods, further driving market growth[1].

Price Projections

Current Pricing

The current prices for baclofen vary based on the form and concentration. For example, oral baclofen tablets can cost around $11 for a supply of 30 tablets, while intrathecal solutions can range from $250.22 to $798.10 for 20 milliliters[5].

Future Pricing Trends

Given the projected market growth and increasing demand, prices may stabilize or slightly increase due to higher production costs and market dynamics. However, reimbursement strategies and competitive market pressures are likely to keep prices manageable for patients.

Intrathecal Baclofen (ITB) Therapy Market

The global market for ITB therapy systems was valued at USD 1.11 billion in 2022 and is expected to reach USD 1.84 billion by 2032, growing at a CAGR of 5.2% during the forecast period. This growth is driven by the increasing prevalence of conditions such as cerebral palsy, multiple sclerosis, and spinal cord injuries, as well as the adoption of supportive reimbursement strategies[2].

Key Takeaways

  • Market Growth: The baclofen market is expected to grow at a CAGR of 11.4% from 2024 to 2034.
  • Regional Dominance: North America leads the market, followed by Europe.
  • Key Drivers: Increasing prevalence of neurological disorders, advancements in pharmaceutical formulations, and supportive reimbursement strategies.
  • Market Segments: Oral tablets, oral liquids, intrathecal solutions, and various distribution channels.
  • Competitive Landscape: Major players include Amneal Pharmaceuticals, Novartis AG, and Teva Pharmaceutical Industries Ltd.
  • Price Projections: Prices are expected to stabilize or slightly increase due to market dynamics.

FAQs

What is the current market size of the baclofen market?

The global baclofen market was valued at approximately USD 16,524.27 million in 2024[1].

What is the projected growth rate of the baclofen market?

The market is projected to grow at a CAGR of 11.4% from 2024 to 2034[1].

Which region dominates the baclofen market?

North America dominates the global baclofen market, accounting for around 38% of the market share in 2023[1].

What are the key drivers of the baclofen market growth?

Key drivers include the increasing prevalence of neurological disorders, advancements in pharmaceutical formulations, and supportive reimbursement strategies[2][3].

What is the cost range for intrathecal baclofen solutions?

The cost for intrathecal baclofen solutions can range from $250.22 to $798.10 for 20 milliliters, depending on the concentration and pharmacy[5].

What is the projected market size for Intrathecal Baclofen (ITB) therapy systems by 2032?

The global market for ITB therapy systems is expected to reach USD 1.84 billion by 2032, growing at a CAGR of 5.2% during the forecast period[2].

Sources

  1. We Market Research: Global Baclofen Market Size | 2024-2034[1]
  2. GlobeNewswire: Global Intrathecal Baclofen (ITB) Therapy Systems Market[2]
  3. Market Research Intellect: Baclofen Market Size, Growth, Share | Analysis by 2031[3]
  4. OpenPR: Baclofen Market Set to Witness Significant Growth by 2024-2031[4]
  5. Drugs.com: Baclofen Prices, Coupons, Copay Cards & Patient Assistance[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.